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Introduction and objectives. Clinical studies has showed the efﬁcacy of stereotactic body radiation therapy (SBRT) for pain control
with consequent improvement of quality of life, and also secondary to local tumor control a longer survival in oligometastatic
disease. We present our initial experience using SBRT for bone metastasis in single fraction with 16Gy in oligometastatic disease.
Material and methods. Selection criteria: Patients with localized bone metastasis, up to three separate sites are permitted by
imaging study (bone scan, PET, CT or MRI), in case of spinal lesions each of the separate sites may have a maximal involvement
of two contiguous vertebral bodies. At the moment, we have treated three female patients, two of 47 and one of 51 year old; the
primary histology are breast, lung and neuroendocrine, all of they had a single bone lesion, two had spinal lesion in D12 and
one in sacrum who had pain with numerical rating pain scale of 8/10. Primary tumors were treated with curative intent by their
respective protocol. The bone metastases were treated with SBRT with 16Gy in a single fraction. The follow-up are planning at
1, 3, 6, 12 and 24 months from treatment time, with physical examination, rating de pain at each visit and PET at second visit
(three months from treatment).
Results. Currently we have a mean follow-up of eight months, no adverse effect was detected, the patient who had pain, showed
a complete pain relief. All of these patients are in local tumor control, evaluated with PET at three months from treatment.
Conclusion. SBRT in a single fraction of 16Gy to bone metastasis was well tolerated in this series, without toxicity at the moment,
and good local control. Although this is a small series, seems than long-term results can showus a newperspective in oligometas-
tasic disease patients.
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Introduction. Adaptive radiation therapy is a closed-loop radiation treatment process where the treatment plan can be modiﬁed
using a systematic feedback frommeasurements. It is especially relevant in SBRT treatmentswhere tumour shrinkage is frequent
between fractions. The whole process must be sufﬁciently fast and straightforward to be feasible. Increasing number of software
options are now showing up in the market.
Purpose. To describe a new procedure for adaptive radiotherapy in SBRT treatments by using the Treatment Planning System
(TPS) tools for image fusion and assignment of electronic densities.
Material and methods. A CT simulation for SBRT using the immobilization system eXaCradle (Anatomical Geometry) is performed.
The treatment is designed in TPS Pinnacle-v9.2. A kV-CBCT is performed prior to each fraction. Image matching is executed
ensuring that the center of mass of tumours in both set of images is the same. In case of differences in margins between the
observed and the simulated GTV bigger than 3mm, the treatment is not delivered. The CBCT images are sent to the TPS where
they are fussed with simulation ones. The precise immobilization that eXaCradle provides ensure a correct image fusion. On the
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